Trials / Completed
CompletedNCT01058525
Influence of Ultrasonographic Hydro-dissection With Glucose 5% on Nerve Block Efficiency
Influence of Ultrasonographic Hydro-dissection With Glucose 5% Solution on Median Nerve Block Efficiency: a Prospective and Randomized Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The real-time visualization of a needle and nerve during an ultrasound-guided nerve block can be challenging. These difficulties may partly explain the systemic complications of local anesthetics under ultrasound. Injection of small amounts of a solution around the anesthetized nerve (hydro-dissection) has been proposed to enhance contrast outlining its borders and also to improve the visualization of the needle tip. The glucose solution 5% solution is interesting because it allows, unlike saline, to maintain the motor response with neurostimulation. The hydro-dissection can be particularly useful when one suspect hypoechoic vessels near the nerve to be anesthetized. Thereby, the nerve well demarcated and separated from the vessels, injection of local anesthetic is performed in the circumferential diffusion space (like a small pocket) without redirecting needle. The influence of this hydro-dissection on the nerve block efficiency is unknown. The nerve block quality can be improved because the entire anesthetic is injected in contact with the nerve, but it can also be reduced due to the dilution of the local anesthetic by the glucose solution. In this randomized study, the investigators test the hypothesis that hydro-dissection does not alter the nerve block onset time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | median nerve block | median nerve block performed using ultrasound guidance |
| PROCEDURE | median nerve block after hydro-dissection | median nerve block performed after hydro-dissection (glucose 5% solution), both using ultrasound guidance |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2010-01-28
- Last updated
- 2016-09-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01058525. Inclusion in this directory is not an endorsement.